Skip to main content
. 2013 Sep 13;14:83. doi: 10.1186/1471-2156-14-83

Table 2.

Strains (RASANs) tested in the study

Strain (abbreviation) n NHap
HapD (SD)
NPS
π (SD)
k
HVR1 W HVR1 W HVR1 W HVR1 W HVR1 W
Kahlila (K)
44
22
26
0.94(0.022)
0.95(0.022)
41
61
0.023(0.0006)
0.0149(0.0005)
9.9
14.2
Hamadania (H)
61
12
14
0.87(0.019)
0.88(0.02)
32
52
0.019(0.0009)
0.0148(0.0006)
8.4
14.1
Hadbaa (HD)
7
3
3
0.76(0.115)
0.76(0.115)
17
24
0.019(0.003)
0.0125(0.002)
8.5
12.0
Dahmaa (D)
7
2
2
0.57(0.119)
0.57(0.119)
11
19
0.014 (.0029)
0.0113(0.0023)
6.3
10.8
Saklawia (S)
43
14
15
0.92(0.019)
0.92(0.02)
33
48
0.019(0.001)
0.0127(0.0006)
8.4
12.1
Abiah (A)
24
10
10
0.85(0.053)
0.85(0.053)
28
39
0.019(0.0015)
0.012(0.001)
8.7
11.7
Shweemat (SH)
5
1
1
0
0
0
0
0
0
0
0
all 191 44 55 0.96(0.004) 0.97(0.004) 52 81 0.0218(0.0006) 0.0151(0.0004) 9.9 14.4

n number of individuals in each strain. NHap the number of haplotypes resulted in each strain. HD Haplotype diversity with its standard deviation. NPS the number of polymorphic sites. π Nucleotide diversity with its standard deviation. k Average number of nucleotide differences. HVR1 part of the upstream D-loop (450 sites). W the whole D-loop (951 sites).